Quisovalimab | m-entrepreneurship.com

Product Name :
Quisovalimab

Search keywords :
Quisovalimab

drugId :
null

Target Vo:
Tumor necrosis factor superfamily member 14

Target Vo Short Name :
TNFSF14

Moa_Name:
Tumor necrosis factor superfamily member 14 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
La Jolla Pharmaceutical Company

Active Company_Name :
Aevi Genomic Medicine

Active Indication_Name:
Asthma

In Active Indication_Name:
Crohn Disease

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Visugromab web
JNK Rabbit mAb MedChemExpress
Phospho-Tau (Ser404) Antibody: Phospho-Tau (Ser404) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Phospho-Tau (Ser404). It can be used for WB assays with tag free, in the background of Human, Rat.

Author: Betaine hydrochloride

Related Posts